A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

A team of scientists led by the National Cancer Center Singapore (NCCS) and Duke-NUS Medical School (Duke-NUS) has found a new approach for treating some of the world's most aggressive cancers ...

Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a ...

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, ...

A diagnosis of ductal carcinoma in situ, or DCIS, often comes as a surprise during a routine mammogram. While the news is understandably taxing, it is important to remember that DCIS is a noninvasive, ...

A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

Incidence and diagnosis of neuroendocrine tumors (NETs) have risen significantly over the last several decades. According to research published in JAMA Network Open in 2025, the incidence of NETs ...

Basal cell carcinoma is the most common skin cancer, often caused by UV exposure, and originates in the epidermis's basal cells. Diagnosis involves clinical examination and biopsy to confirm BCC and ...

The risk of missing aggressive appendiceal tumors in patients with acute appendicitis treated with antibiotics only was very ...

Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most challenging malignancies to treat due to its highly ...

In this segment focused on advanced renal cell carcinoma, Dr. Geynisman shifts the discussion to patients with intermediate ...